{"schema_version":"secwatch.filing_event.v1","accession":"0001698530-25-000004","form_type":"8-K","ticker":"XCUR","cik":"0001698530","company_name":"EXICURE, INC.","filed_at":"2025-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.485114+00:00","generated_at":"2026-05-27T19:50:51.513057+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"medium","headline":"Exicure buys GPCR USA for ~$1.62M; milestone & royalty deal with GPCR Therapeutics","bullets":["Acquired all outstanding shares of GPCR Therapeutics USA from GPCR Therapeutics for ~$0.27/share (total ~$1.62M).","Entered License and Collaboration Agreement to develop and commercialize GPCR's IP; includes milestone payments and 10% royalty on net sales.","Example milestone: $30M payment when first annual net sales exceed $400M.","Deal closed concurrently with execution on January 19, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001698530-25-000004","json":"https://secwatch.observer/filing/0001698530-25-000004.json","markdown":"https://secwatch.observer/filing/0001698530-25-000004.md","text":"https://secwatch.observer/filing/0001698530-25-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1698530/000169853025000004/0001698530-25-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1698530/000169853025000004/xcur-20250119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T19:50:51.513057+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}